Practice current: How do you treat neuromyelitis optica?
作者信息
Ganesh Aravind
机构信息
Department of Clinical Neurosciences, University of Calgary, Canada; and Centre for Prevention of Stroke and Dementia, Nuffield Department of Clinical Neurosciences, University of Oxford, UK.
出版信息
Neurol Clin Pract. 2017 Apr;7(2):170-178. doi: 10.1212/CPJ.0000000000000352.
Abstract
摘要
相似文献
1
Practice current: How do you treat neuromyelitis optica?
Neurol Clin Pract. 2017 Apr;7(2):170-178. doi: 10.1212/CPJ.0000000000000352.
2
Reader Response: Practice Current: How do you treat neuromyelitis optica?
Neurol Clin Pract. 2018 Aug;8(4):276. doi: 10.1212/CPJ.0000000000000497.
3
Author Response: Practice Current: How do you treat neuromyelitis optica?
Neurol Clin Pract. 2018 Aug;8(4):276-277. doi: 10.1212/CPJ.0000000000000498.
4
Presentation of neuromyelitis optica spectrum disorder after more than twenty years of systemic sclerosis.
Mult Scler Relat Disord. 2012 Oct;1(4):202-3. doi: 10.1016/j.msard.2012.04.002. Epub 2012 Jun 20.
5
[Diagnostic criteria in acute neuromyelitis].
Oftalmologia. 2007;51(4):116-20.
6
Individualized rituximab treatment for relapsing neuromyelitis optica: a pediatric case report.
Pediatr Neurol. 2014 Aug;51(2):255-8. doi: 10.1016/j.pediatrneurol.2014.01.039. Epub 2014 Jan 24.
7
The spectrum of neuromyelitis optica.
Lancet Neurol. 2007 Sep;6(9):805-15. doi: 10.1016/S1474-4422(07)70216-8.
8
Neuromyelitis optica with onset in childhood and adolescence.
Pediatr Neurol. 2014 Jan;50(1):66-8. doi: 10.1016/j.pediatrneurol.2013.07.003. Epub 2013 Oct 13.
9
Expanding the spectrum of neuromyelitis optica: friend or foe?
Curr Opin Ophthalmol. 2007 Nov;18(6):459-62. doi: 10.1097/ICU.0b013e3282f0b3bf.
10
Prolonged Remission in Neuromyelitis Optica Following Cessation of Rituximab Treatment.
J Child Neurol. 2015 Sep;30(10):1366-70. doi: 10.1177/0883073814553974. Epub 2014 Nov 10.
引用本文的文献
1
Odd O in NMO: isolated Horner syndrome without optic neuritis in a patient with neuromyelitis optica.
BMJ Case Rep. 2019 Sep 12;12(9):e232205. doi: 10.1136/bcr-2019-232205.
2
Author Response: Practice Current: How do you treat neuromyelitis optica?
Neurol Clin Pract. 2018 Aug;8(4):276-277. doi: 10.1212/CPJ.0000000000000498.
3
Reader Response: Practice Current: How do you treat neuromyelitis optica?
Neurol Clin Pract. 2018 Aug;8(4):276. doi: 10.1212/CPJ.0000000000000497.
本文引用的文献
1
Neuromyelitis Optica Spectrum Disorders.
Continuum (Minneap Minn). 2016 Jun;22(3):864-96. doi: 10.1212/CON.0000000000000337.
2
Neuromyelitis optica relapses: Race and rate, immunosuppression and impairment.
Mult Scler Relat Disord. 2016 May;7:21-5. doi: 10.1016/j.msard.2016.02.014. Epub 2016 Feb 16.
3
Placebo-controlled study in neuromyelitis optica-Ethical and design considerations.
Mult Scler. 2016 Jun;22(7):862-72. doi: 10.1177/1352458515620934. Epub 2015 Dec 14.
4
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.
Neurology. 2015 Jul 14;85(2):177-89. doi: 10.1212/WNL.0000000000001729. Epub 2015 Jun 19.
5
Protocol for a multicentre randomiSed controlled TRial of IntraVEnous immunoglobulin versus standard therapy for the treatment of transverse myelitis in adults and children (STRIVE).
BMJ Open. 2015 May 25;5(5):e008312. doi: 10.1136/bmjopen-2015-008312.
6
Placebo studies should not be undertaken in NMO--No.
Mult Scler. 2015 May;21(6):691-3. doi: 10.1177/1352458515579217. Epub 2015 Apr 28.
7
Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease.
Mult Scler. 2015 Jun;21(7):866-874. doi: 10.1177/1352458514555785. Epub 2014 Oct 24.
8
Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO.
Neurol Neuroimmunol Neuroinflamm. 2014 Oct 9;1(3):e34. doi: 10.1212/NXI.0000000000000034. eCollection 2014 Oct.
9
Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy.
JAMA Neurol. 2014 Mar;71(3):324-30. doi: 10.1001/jamaneurol.2013.5699.
10
Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
JAMA Neurol. 2014 Mar;71(3):276-83. doi: 10.1001/jamaneurol.2013.5857.
Zotero 插件